Suppressors of Cytokine Signaling and Hepatocellular Carcinoma

Ryota Masuzaki1, Tatsuo Kanda1, Reina Sasaki1

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Itabashi, Tokyo 173-8610, Japan.

Cancers
|May 28, 2022
PubMed

Insights

Suppressors of cytokine signaling (SOCS) proteins regulate cell growth and immune responses. This review highlights SOCS proteins as potential therapeutic targets for hepatocellular carcinoma (HCC) and other liver diseases.

Area of Science:

  • Molecular Biology
  • Immunology
  • Hepatology

Background:

  • Cytokines are crucial for cell growth and differentiation, with Suppressors of Cytokine Signaling (SOCS) proteins acting as negative regulators.
  • The SOCS family comprises eight members, each with distinct roles in cellular signaling pathways.
  • SOCS proteins are implicated in regulating cytokine and growth factor signaling in various liver diseases, including viral hepatitis and hepatocellular carcinoma (HCC).

Purpose of the Study:

  • To review recent findings on the role of SOCS family proteins in liver diseases, with a focus on hepatocellular carcinoma (HCC).
  • To explore the potential of SOCS proteins as therapeutic targets for HCC, considering their influence on cell proliferation, differentiation, and immune response.

Main Methods:

  • Literature review summarizing recent research on SOCS proteins in liver diseases and HCC.
  • Analysis of the involvement of specific SOCS proteins (SOCS1, SOCS3, SOCS2) in immune response, liver regeneration, and HCC development.

Main Results:

  • SOCS1 and SOCS3 are involved in immune response and inhibit interferon signaling in viral hepatitis.
  • Decreased SOCS3 expression correlates with advanced HCC stage and poor prognosis; DNA methylation of SOCS1 and SOCS3 is observed in HCC.
  • SOCS2 and SOCS3 are induced early during liver regeneration after partial hepatectomy (PH), suggesting a role in liver repair processes.

Conclusions:

  • SOCS signaling plays a significant role in liver regeneration and is implicated in the pathogenesis of HCC.
  • SOCS proteins represent promising therapeutic targets for HCC, offering potential for modulating cell proliferation, differentiation, and immune responses in the tumor microenvironment.

Related Concept Videos

Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K